Search results

641 results

Sorted by Date . Sort by Relevance

  1. The percentage of patients aged 25–84, years with a new diagnosis of hypertension or type 2 diabetes, recorded between the preceding 1 April to 31 March (excluding those with pre-existing CHD, stroke and/or TIA) who have had a consultation for cardiovascular risk assessment using the QRISK2 risk assessment tool between 3 months before or 3 months after date of diagnosis (Inherited)

    The percentage of patients aged 25–84, years with a new diagnosis of hypertension or type 2 diabetes, recorded between the preceding 1 April to 31...

  2. The percentage of patients with a history of myocardial infarction (more than 12 months ago) who are currently being treated with an ACE-I (or ARB if ACE-I intolerant), aspirin (or clopidogrel) (or anticoagulant drug therapy) and a statin and a beta-blocker for those patients with left ventricular systolic dysfunction

    The percentage of patients with a history of myocardial infarction (more than 12 months ago) who are currently being treated with an ACE-I (or ARB if...

  3. In those patients with a new diagnosis of hypertension or type 2 diabetes aged 25-84 years, recorded between the preceding 1 April to 31 March (excluding those with pre-existing CHD, stroke and/or TIA), who have a recorded CVD risk assessment score (using the QRISK2 assessment tool) of 20% in the preceding 12 months: the percentage who are currently treated with statins (unless there is a contraindication)

    In those patients with a new diagnosis of hypertension or type 2 diabetes aged 25-84 years, recorded between the preceding 1 April to 31 March...